-transparent.png){kind=logo}
The kinetics of a single i.v. dose of theophylline given either alone or with flumequine was studied in eight healthy volunteers. No statistically significant differences were observed in the pharmacokinetic parameters of theophylline (volume of distribution, elimination half-life, AUC, plasma clearance) following the two treatments. Pretreatment for 5 days with oral flumequine (400 mg, three times daily) had no significant effect on the disposition of a single i.v. dose of theophylline in healthy volunteers.
Related Publications
B Lacarelle, and
O Blin, and
C Audebert, and
P Auquier, and
H Karsenty, and
F Horriere, and
A Durand
July 1989,
Journal of clinical pharmacology,
B Lacarelle, and
O Blin, and
C Audebert, and
P Auquier, and
H Karsenty, and
F Horriere, and
A Durand
January 1985,
European journal of respiratory diseases,
B Lacarelle, and
O Blin, and
C Audebert, and
P Auquier, and
H Karsenty, and
F Horriere, and
A Durand
March 1998,
Biopharmaceutics & drug disposition,
B Lacarelle, and
O Blin, and
C Audebert, and
P Auquier, and
H Karsenty, and
F Horriere, and
A Durand
June 1991,
Antimicrobial agents and chemotherapy,
B Lacarelle, and
O Blin, and
C Audebert, and
P Auquier, and
H Karsenty, and
F Horriere, and
A Durand
May 1998,
European journal of clinical pharmacology,
B Lacarelle, and
O Blin, and
C Audebert, and
P Auquier, and
H Karsenty, and
F Horriere, and
A Durand
January 1986,
European journal of clinical pharmacology,
B Lacarelle, and
O Blin, and
C Audebert, and
P Auquier, and
H Karsenty, and
F Horriere, and
A Durand
July 1999,
European journal of clinical pharmacology,
B Lacarelle, and
O Blin, and
C Audebert, and
P Auquier, and
H Karsenty, and
F Horriere, and
A Durand
January 1985,
Therapeutic drug monitoring,
B Lacarelle, and
O Blin, and
C Audebert, and
P Auquier, and
H Karsenty, and
F Horriere, and
A Durand
November 1999,
Journal of clinical pharmacology,
B Lacarelle, and
O Blin, and
C Audebert, and
P Auquier, and
H Karsenty, and
F Horriere, and
A Durand
January 1992,
Clinical pharmacokinetics,
